258 related articles for article (PubMed ID: 17207376)
1. Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis.
Gomez-Barrena E; Lindroos L; Ceponis A; López-Franco M; Sanchez-Pernaute O; Mönkkönen J; Salo J; Herrero-Beaumont G; Konttinen Y
Clin Exp Rheumatol; 2006; 24(6):622-8. PubMed ID: 17207376
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-dose, noncytotoxic, intraarticular liposomal clodronate on development of erosions and proteoglycan loss in established antigen-induced arthritis in rabbits.
Ceponis A; Waris E; Mönkkönen J; Laasonen L; Hyttinen M; Solovieva SA; Hanemaaijer R; Bitsch A; Konttinen YT
Arthritis Rheum; 2001 Aug; 44(8):1908-16. PubMed ID: 11508444
[TBL] [Abstract][Full Text] [Related]
3. Local removal of phagocytic synovial lining cells by clodronate-liposomes decreases cartilage destruction during collagen type II arthritis.
Van Lent PL; Holthuysen AE; Van Rooijen N; Van De Putte LB; Van Den Berg WB
Ann Rheum Dis; 1998 Jul; 57(7):408-13. PubMed ID: 9797567
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids.
Hummel KM; Neidhart M; Vilim V; Hauser N; Aicher WK; Gay RE; Gay S; Häuselmann HJ
Br J Rheumatol; 1998 Jul; 37(7):721-8. PubMed ID: 9714346
[TBL] [Abstract][Full Text] [Related]
5. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes.
Recklies AD; Baillargeon L; White C
Arthritis Rheum; 1998 Jun; 41(6):997-1006. PubMed ID: 9627009
[TBL] [Abstract][Full Text] [Related]
6. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints.
Skiöldebrand E; Lorenzo P; Zunino L; Rucklidge GJ; Sandgren B; Carlsten J; Ekman S
Equine Vet J; 2001 Jul; 33(4):394-402. PubMed ID: 11469774
[TBL] [Abstract][Full Text] [Related]
7. Human monoclonal rheumatoid synovial B lymphocyte hybridoma with a new disease-related specificity for cartilage oligomeric matrix protein.
Souto-Carneiro MM; Burkhardt H; Müller EC; Hermann R; Otto A; Kraetsch HG; Sack U; König A; Heinegård D; Müller-Hermelink HK; Krenn V
J Immunol; 2001 Mar; 166(6):4202-8. PubMed ID: 11238672
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
[TBL] [Abstract][Full Text] [Related]
9. Small fragments of cartilage oligomeric matrix protein in synovial fluid and serum as markers for cartilage degradation.
Neidhart M; Hauser N; Paulsson M; DiCesare PE; Michel BA; Häuselmann HJ
Br J Rheumatol; 1997 Nov; 36(11):1151-60. PubMed ID: 9402858
[TBL] [Abstract][Full Text] [Related]
10. Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen-induced arthritis.
Hofkens W; Storm G; van den Berg WB; van Lent PL
Int J Pharm; 2011 Sep; 416(2):486-92. PubMed ID: 21382458
[TBL] [Abstract][Full Text] [Related]
11. Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation.
Akasaki Y; Matsuda S; Nakayama K; Fukagawa S; Miura H; Iwamoto Y
Osteoarthritis Cartilage; 2009 Feb; 17(2):235-43. PubMed ID: 18672387
[TBL] [Abstract][Full Text] [Related]
12. Clodronate exerts an anabolic effect on articular chondrocytes mediated through the purinergic receptor pathway.
Rosa RG; Collavino K; Lakhani A; Delve E; Weber JF; Rosenthal AK; Waldman SD
Osteoarthritis Cartilage; 2014 Sep; 22(9):1327-36. PubMed ID: 25042551
[TBL] [Abstract][Full Text] [Related]
13. High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton.
Oelzner P; Kunze A; Henzgen S; Thoss K; Hein G; Stein G; Bräuer R
Inflamm Res; 2000 Aug; 49(8):424-33. PubMed ID: 11028760
[TBL] [Abstract][Full Text] [Related]
14. A trial of clodronate-liposomes as anti-macrophage treatment in a sheep model of arthritis.
Highton J; Guévremont D; Thomson J; Carlisle B; Tucker I
Clin Exp Rheumatol; 1999; 17(1):43-8. PubMed ID: 10084031
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of leflunomide therapy on the activity of matrixmetalloproteinase-9 and the release of cartilage oligomeric matrix protein in patients with rheumatoid arthritis.
Kullich WC; Mur E; Aglas F; Niksic F; Czerwenka C
Clin Exp Rheumatol; 2006; 24(2):155-60. PubMed ID: 16762150
[TBL] [Abstract][Full Text] [Related]
16. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
[TBL] [Abstract][Full Text] [Related]
17. Differential response of cartilage oligomeric matrix protein (COMP) to morphogens of bone morphogenetic protein/transforming growth factor-β family in the surface, middle and deep zones of articular cartilage.
Motaung SC; Di Cesare PE; Reddi AH
J Tissue Eng Regen Med; 2011 Jun; 5(6):e87-96. PubMed ID: 21604381
[TBL] [Abstract][Full Text] [Related]
18. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.
Jung YO; Do JH; Kang HJ; Yoo SA; Yoon CH; Kim HA; Cho CS; Kim WU
Clin Exp Rheumatol; 2006; 24(3):253-9. PubMed ID: 16870091
[TBL] [Abstract][Full Text] [Related]
19. Cartilage oligomeric matrix protein deficiency promotes early onset and the chronic development of collagen-induced arthritis.
Geng H; Carlsen S; Nandakumar KS; Holmdahl R; Aspberg A; Oldberg A; Mattsson R
Arthritis Res Ther; 2008; 10(6):R134. PubMed ID: 19014566
[TBL] [Abstract][Full Text] [Related]
20. Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis.
Richards PJ; Williams AS; Goodfellow RM; Williams BD
Rheumatology (Oxford); 1999 Sep; 38(9):818-25. PubMed ID: 10515641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
